sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Mea Respiratory Tract Infection Treatment Market Scope And Analysis

  • Report Code : TIPRE00038996
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 201
Buy Now

MEA-Markttrends zur Behandlung von Atemwegsinfektionen, Umfangsanalyse bis 2024-2031

Buy Now

MEA Respiratory Tract Infection Treatment Market Report MEA Respiratory Tract Infection Treatment Market Size and Share MEA Respiratory Tract Infection Treatment Market Scope and Analysis

MEA Respiratory Tract Infection Treatment Market Report Scope

Report Attribute Details
Market size in 2023 US$ 2,092.80 Million
Market Size by 2031 US$ 2,975.09 Million
Global CAGR (2023 - 2031) 4.50%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Arzneimittel
  • Antibiotika
  • NSAR
  • Hustenstiller
  • Nasenabschwellmittel
By Krankheitsindikation
  • Infektion der oberen Atemwege und der unteren Atemwege
By Verabreichungsweg
  • oral und parenteral
By Altersgruppe
  • Kinder und Erwachsene
Regions and Countries Covered Naher Osten und Afrika
  • Südafrika
  • Saudi-Arabien
  • Vereinigte Arabische Emirate
  • Rest des Nahen Ostens und Afrikas
Market leaders and key company profiles
  • Abbott Laboratories
  • AstraZeneca plc
  • Alembic Pharmaceuticals Ltd.
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd
  • Novartis AG
  • F. Hoffmann-La Roche AG
  • Sanofi S.A.